Avicanna Inc (TSE:AVCN) has released an update.
Avicanna Inc., a biopharmaceutical company, has launched RHO Phyto Micro Drop 100, a new THC-free, 10% CBD oral formulation in Canada, with exclusive availability through MyMedi.ca. This product, which uses advanced absorption technology, parallels the company’s Trunerox™, approved in Colombia for severe seizure treatments. Avicanna is also preparing for a medical symposium on cannabinoid medicine, reinforcing its commitment to research and development in the field.
For further insights into TSE:AVCN stock, check out TipRanks’ Stock Analysis page.
